Endoscopic surveillance of barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer

Objective:Endoscopic surveillance of Barrett's esophagus is commonly practiced to detect malignancy in an early and curable stage. However, the cost-effectiveness of this practice has been questioned. To clarify this issue, we undertook a cost analysis of endoscopic surveillance to detect adenocarcinoma in Barrett's esophagus compared with mammography used to detect occult carcinoma of the breast, a widely accepted cancer surveillance technique.Methods:The rate of esophageal adenocarcinoma detected by endoscopic surveillance was calculated for Duluth Clinic patients with Barrett's esophagus seen from 1980 to 1995 and compared with published rates. The rate of occult breast cancer detection was calculated for all women undergoing surveillance mammography at the Duluth Clinic for the year 1994 and compared with published rates. Costs for screening studies and therapy for cancer treatment for both cancers were calculated based on clinical results and assumptions regarding outcomes derived from published reports, and the costs were compared.Results:Endoscopic surveillance of 149 patients with benign Barrett's esophagus was performed for a total of 510 patient-yr, during which time seven patients developed adenocarcinoma, an incidence of one case per 73 patient-yr of follow-up. Occult breast cancer was detected in 50 of 12,537 mammograms, a detection rate of 0.4%. The incidences in both cases were comparable to published figures. The costs of detecting a case of adenocarcinoma in Barrett's esophagus and occult breast cancer were $37,928 and $54,513, respectively, and those for treatment resulting in cure were $83,340 and $83,292. Cost per life-yr saved was $4,151 for adenocarcinoma in Barrett's esophagus and $57,926 for breast cancer.Conclusion:Endoscopic surveillance of patients with Barrett's esophagus compares favorably with the common practice of surveillance mammography to detect early breast cancer, and should therefore be considered to be as cost-effective as surveillance mammography.

[1]  G. Falk,et al.  Barrett's esophagus and adenocarcinoma. The need for a consensus conference. , 1996, Journal of clinical gastroenterology.

[2]  W. Hop,et al.  Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. , 1995, Gut.

[3]  D C Slawson,et al.  Efficacy of screening mammography. , 1995, The Journal of family practice.

[4]  S Hellman,et al.  Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  S. Rubin,et al.  Efficacy of screening mammography. A meta-analysis. , 1995, JAMA.

[6]  N. Devlin,et al.  The costs of mammography screening in New Zealand: evidence from the pilot programmes. , 1994, The New Zealand medical journal.

[7]  M. Sasa,et al.  High Detection Rate of Breast Cancer by Mass Screening Using Mammography in Japan , 1994, Japanese journal of cancer research : Gann.

[8]  J B Wong,et al.  A guide for surveillance of patients with Barrett's esophagus. , 1994, The American journal of gastroenterology.

[9]  J Chamberlain,et al.  National Health Service breast screening programme results for 1991-2. , 1993, BMJ.

[10]  Noriaki Ohuchi,et al.  Improved Detection Rate of Early Breast Cancer in Mass Screening Combined with Mammography , 1993, Japanese journal of cancer research : Gann.

[11]  F. Ellis,et al.  Endoscopic surveillance of Barrett's esophagus. Does it help? , 1993, The Journal of thoracic and cardiovascular surgery.

[12]  M. R. del Turco,et al.  First Results of a Mammographic Screening Program in Two Municipalities of Massa-Carrara Province (Italy) , 1993, Tumori.

[13]  P. Pairolero,et al.  Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? , 1992, The Annals of thoracic surgery.

[14]  F. Ellis,et al.  Barrett's esophagus. Prevalence and incidence of adenocarcinoma. , 1991, Archives of internal medicine.

[15]  J. Eisenberg,et al.  Clinical Economics: A Guide to the Economic Analysis of Clinical Practices , 1989 .

[16]  C. Carter,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.

[17]  J. G. van den Tweel,et al.  Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.

[18]  J. Blankensteijn,et al.  Adenocarcinoma in Barrett's oesophagus: an overrated risk. , 1989, Gut.

[19]  J. Mayberry,et al.  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.

[20]  E. Achkar,et al.  The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. , 1988, The American journal of gastroenterology.

[21]  W G Doos,et al.  Adenocarcinoma and Barrett's esophagus. An overrated risk? , 1984, Gastroenterology.

[22]  B. Ramshaw,et al.  Twenty‐year review of a breast cancer screening project: Ninety‐five percent survival of patients with nonpalpable cancers , 1996, Cancer.

[23]  E. Sickles,et al.  Clinical efficacy of mammographic screening in the elderly. , 1995, Radiology.

[24]  J. Daurès,et al.  [Mass screening for breast cancer in Herault county. First results in women between 40 and 70 years old]. , 1992, Journal de gynecologie, obstetrique et biologie de la reproduction.

[25]  T. Hislop,et al.  The British Columbia Mammography Screening Program: evaluation of the first 15 months. , 1992, AJR. American journal of roentgenology.

[26]  N. Altorki,et al.  High-grade dysplasia in the columnar-lined esophagus. , 1991, American journal of surgery.

[27]  F. Pruvot,et al.  The incidence of cancer in Barrett’s esophagus vary according to series , 1989 .

[28]  R. McCallum,et al.  Benign Lesions of the Esophagus and Cancer , 1989, Springer Berlin Heidelberg.

[29]  D. Commerce.  Statistical abstract of the United States , 1978 .